Lymphangitis as a complication of intralesional bleomycin therapy.
Allen
A L
AL
Department of Dermatology, St. Louis University School of Medicine, Missouri 63104, USA.
Fosko
S W
SW
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D001761:Bleomycin / Q000008:administration & dosage / Q000009:adverse effects*; D002908:Chronic Disease; D005528:Foot / Q000473:pathology; D005533:Foot Dermatoses / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D015552:Injections, Intralesional; D008205:Lymphangitis / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D014860:Warts / Q000150:complications* / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D001761:Bleomycin